Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Fiziol Zh (1994) ; 49(3): 80-9, 2003.
Artigo em Russo | MEDLINE | ID: mdl-12918255

RESUMO

Chronic inflammatory gynecological diseases (CIGD) in highlanders (2,100-2,200 m a.s.l.) are accompanied with the following changes in immunoregulatory parameters: strengthening in the expression of CD3+ (TCR), CD4+ (T-helpers), CD16+ (NK-cells), CD25+ (activated IL-2R), increase in CD4+/CD8+ ratio, levels of circulating cytokines--alpha-, beta-, gamma-interferon (IFN) and alpha-, beta-tumor necrotizing factor (TNF), strengthening in immune adhesion of thrombocytes (IAT), and inhibition of the oxidative metabolic way of L-arginine with redistribution of the main metabolites formed via its non-oxidative way. Complex extremely high frequency (EHF) therapy and interferon (with Laferon) therapy of CIGD normalized expression of the differentiated and functional CD-markers of immunocompetent cells (ICC), CD4+/CD8+ ratio, increased expression of CD8+, decreased IAT and levels of circulating cytokines (IFN, TNF), changed L-arginine metabolism with activation of the oxidative way. Full-value of the population signs of immune stabilization due to the treatment was complemented with increase in the ICC functional parameters--markers of mitochondrial, lysosomal and mitotic activity. We first demonstrated a high effectiveness of complex use of EHF and Laferon as an immunocorrective therapy of CIGD in highlanders.


Assuntos
Altitude , Arginina/metabolismo , Citocininas/sangue , Interferon Tipo I/uso terapêutico , Micro-Ondas/uso terapêutico , Doença Inflamatória Pélvica , Adulto , Antígenos CD/sangue , Biomarcadores/sangue , Terapia Combinada , Feminino , Humanos , Hipóxia/metabolismo , Interferon-alfa , Células Matadoras Naturais/metabolismo , Pessoa de Meia-Idade , Doença Inflamatória Pélvica/imunologia , Doença Inflamatória Pélvica/metabolismo , Doença Inflamatória Pélvica/terapia , Receptores de Antígenos/biossíntese , Proteínas Recombinantes , Linfócitos T Auxiliares-Indutores/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...